Article
NAD+ supplementation limits triple-negative breast cancer metastasis via SIRT1-P66Shc signaling
23 Jan 2023
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
